抗黴速定水溶性軟膏

Country: Taiwan

Bahasa: Cina

Sumber: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Bahan aktif:

CLOTRIMAZOLE

Boleh didapati daripada:

臺灣拜耳股份有限公司 臺北市信義區信義路5段7號53樓 (23167184)

Borang farmaseutikal:

軟膏劑

Komposisi:

CLOTRIMAZOLE (8404800400) 0.01GM

Unit dalam pakej:

管裝

Kelas:

製　劑

Jenis preskripsi:

須由醫師處方使用

Dikeluarkan oleh:

BAYER AG. D-51368 LEVERKUSEN GERMANY DE

Tanda-tanda terapeutik:

皮黴癬菌、酵母菌屬、黴菌及真菌所引起之皮黴菌病、皮黴菌之繼發感染病

Ringkasan produk:

註銷日期: 1991/08/14; 註銷理由: 自請註銷; 有效日期: 1993/01/05; 英文品名: CANESTEN CREAM

Status kebenaran:

已註銷

Tarikh kebenaran:

1989-07-20

Risalah maklumat

卡黴速停
®
加強型
CANESTEN
® EXTRA
衛署藥輸字第
017337
號
主成分：
Bifonazole
(Tinea pedum, tinea pedum interdigitalis)
(Tinea corporis, tinea manuum, tinea inguinalis)
(
)
3
2-3
2
2-4
0.01
bifonazole
Cetostearyl alcohol, octyldodecanol, polysorbate 60,
sorbitan stearate, benzyl alcohol, purified water, cetyl palmitate.
●
(
)
●
(Erythrasma)
Erythrasma caused by corynebacterium minutissimum.
20
30
(
)
BIFONAZOLE
BIFONAZOLE
IMIDAZOLE
(
ECONAZOLE,
CLOTRIMAZOLE, MICONAZOLE)
BIFONAZOLE
BIFONAZOLE
WARFARIN
INR
BIFONAZOLE
BIFONAZOLE
BIFONAZOLE
BIFONAZOLE
BIFONAZOLE
BIFONAZOLE
BIFONAZOLE
BIFONAZOLE
Bifonazole
imidazole
Malassezia
furfur
Corynebacterium
minutissimum
Bifonazole
bifonazole
Bifonazole
ergosterol
azole
ergosterol
Bifonazole
6
(
)
1000 μg/cm
3
5 μg/cm
3
Bifonazole
100
Kern Pharma, S.L.
Poligono Industrial Colon II, C/ Venus 72, 08228,
Terrassa (Barcelona), Spain
7
54
[phone]
CANESTEN
® EXTRA
Active ingredient: Bifonazole
Kern Pharma, S.L.
Poligono Industrial Colon II, C/ Venus 72, 08228, Terrassa
(Barcelona), Spain
QUANTITATIVE COMPOSITION
1 g cream contains 0.01 g bifonazole
INDICATION(S)
• Treatment of skin mycoses caused by dermatophytes, yeasts,
moulds, and other fungi (e.g. tinea pedis, tinea manuum, tinea
corporis, tinea inguinalis, pityriasis versicolor, superficial
candidiasis)
• Treatment of erythrasma.
POSOLOGY AND METHOD OF ADMINISTRATION
Canesten Extra is convenient to use, it shall be used once a
day in the evening before retiring. It should be applied thinly to
the affected skin area and rubbed in.
To achieve a lasting cure, treatment with bifonazole must be
carried out reliably and over an adequate period. The usual
periods of treatment are summarized in the table below:
USE IN CHILDREN
No in-depth studies have been performed in children. From a
survey of the clinical data reported there is no indication that
harmful effects should be anticipated in children.
However, in infants and toddlers, the medicinal product should
only be used under medical supervisio